Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: A randomized Phase II study

The radiosensitizing combination of GC achieved a greater pathologic response rate than C in the treatment of cervical cancer.